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Recognized issues with poor hand hygiene compliance among healthcare workers and
reports of recontamination of previously chemically disinfected surfaces through hand
contact emphasize the need for novel hygiene methods in addition to those currently
available. One such approach involves antimicrobial (nano) coatings (AMCs), whereby in-
tegrated active ingredients are responsible for elimination of micro-organisms that come
into contact with treated surfaces. While widely studied under laboratory conditions with
promising results, studies under real-life healthcare conditions are scarce. The views of 75
contributors from 30 European countries were collated regarding specialized cleaning
associated with AMCs for reduction of healthcare-associated infection.
There was unanimous agreement that generation of scientific guidelines for cleaning of
AMCs, using traditional or new processes, is needed. Specific topics included: under-
standing mechanisms of action of cleaning materials and their physical interactions with
conventional coatings and AMCs; that assessments mimic the life cycle of coatings to
determine the impact of repetitive cleaning and other aspects of ageing (e.g. exposure to
sunlight); determining concentrations of AMC-derived biocides in effluents; and develop-
ment of effective de-activation and sterilization treatments for cleaning effluents.
Further, the consensus opinion was that, prior to widespread implementation of AMCs,
there is a need for clarification of the varying responsibilities of involved clinical,
healthcare management, cleaning services and environmental safety stakeholders.
ª 2018 The Author(s). Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ical School, University of Limerick, Limerick, Ireland. Tel.: þ353 61 234703.
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to expert riskebenefit analyses that incorporate objectiveHealthcare-associated infections (HCAIs) are preventable to
some extent [1]. Hand hygiene is widely regarded as the most
effective preventative measure for healthcare workers [1]
when complementing effective hospital hygiene practices
that ensure proper cleaning and appropriate use of disinfec-
tants and antimicrobials. However, the recognized issue with
poor hand hygiene compliance among healthcare workers [2],
and reports of recontamination of previously chemically dis-
infected clinical surfaces through hand contact [3], emphasize
a need for novel hygiene methods in addition to those currently
available. One such approach involves antimicrobial (nano)
coatings (AMCs) [4], in which integrated active ingredients are
responsible for the elimination of micro-organisms that come
into contact with treated surfaces. Many different chemical
strategies and technologies for antibacterial coatings have
been described that utilize active eluting agents (e.g. ions or
nanoparticles of silver, copper, zinc, antibiotics, chloride,
iodine, etc.), immobilized molecules that become active upon
contact (e.g. quaternary ammonium polymers or peptides) or
light-activatedmolecules (e.g. TiO2 or photosensitizers). These
coatings have been widely studied under laboratory conditions
with promising results [3,5,6], bolstered by reports describing
successful delay and/or prevention of recontamination
following conventional cleaning and disinfection by problem-
atic microbes such as meticillin-resistant Staphylococcus
aureus and vancomycin-resistant enterococci, amongst others
[5]. However, efficacy studies performed under real-life con-
ditions in healthcare settings are relatively scarce.
More broadly, a 2016 comprehensive systematic review re-
ported a paucity of studies evaluating non-copper anti-
microbial surfaces in clinical environments, and a lack of peer-
reviewed data relating to successful implementation of mate-
rials other than copper on clinically relevant outcomes
(including HCAIs) [7]. Researchers have demonstrated suc-
cessfully that copper touch surfaces in Finnish facilities such as
hospital patient rooms and kindergartens lowered total bac-
terial counts and reduced the occurrence of S. aureus when
compared with non-copper touch surfaces [8]. Michels et al.
described the efficacy of copper alloy based on compelling
data generated in sequential laboratory and clinical trial as-
sessments [9]. Molling et al. [10] reported a dominance of
nanosilver in nanoparticle-based coatings and associated
adequate in-situ performance. However, Ortı´-Lucas and
Mun˜oz-Miguel [11] reported that while coating of hospital sur-
faces with substances containing silver ions may reduce bac-
terial growth, the effectiveness of the coating agent is affected
by application method, environmental conditions, and the type
and cleanness of the surface.
Therefore, caution is needed. The introduction of (nano)
coatings with novel active components (e.g. nanosilver), some
of which may be affected by varying end-user cleaning
methods, could possibly cause emission of bioactive agents into
the environment, and facilitate potential exposure of humans,
livestock and micro-organisms to low concentrations of these
agents. Directly relevant to the One Health Initiative (http://
www.onehealthinitiative.com), these agents (e.g. AgNP, Agþ,
CuNP, ZnO2 and TiO2) may have potential to impact organisms
living in water and soil compartments. In addition, the slow
infusion of active ingredients may induce antimicrobial resis-
tance that differs from antibiotic-driven mechanisms [12,13].assessment of available coatings and guidance for hospital
systems regarding their use; for example, the Scientific Com-
mittee on Emerging and Newly Identified Health Risks of nano-
silver specifically (https://ec.europa.eu/health/scientific_
committees/emerging/docs/scenihr_o_039.pdf), or the EU-
COST Action AMiCI (AntiMicrobial Coating Innovations)
CA15114 regarding AMC technologies and their usemore broadly
[14,15]. More specifically, AMiCI is an initiative funded by the
European Commission through its Cooperation in Science and
Technology (COST) programme. In this case, the four-year
initiative has established a network of experienced stake-
holders who are engaged actively in development, regulation
and use of novel AMCs for prevention of HCAIs. They are not
researchers or clinicians at an early stage of their career
(although mentorship and mobility of these is enabled through
specific programmes). The network (AMiCI) comprises partici-
pants of more than 60 universities, research institutes, hospi-
tals and companies across 30 European countries, and
represents themost comprehensive consortium targeting use of
these emergent technologies in healthcare settings. In partic-
ular, the network prioritizes coordinated research on the ef-
fects (both positive and negative) of AMCs in healthcare
sectors; know-how regarding availability and mechanisms of
action of (nano) coatings; possible adverse effects of such
materials (e.g. potential emergence of microbial resistance or
emission of toxic agents into the environment); standardized
performance assessments for AMCs; and identification and
dissemination of best practices by hospitals, other clinical fa-
cilities, regulators and manufacturers. Using a consultation
process that previously elicited the opinions of expert stake-
holders regarding safe use of AMCs [16], views were collated
regarding specialized cleaning associated with AMCs for
reduction of HCAIs. Particular emphasis was placed on aware-
ness of new cleaning approaches that may impact the effec-
tiveness of AMCs, the generation of effluent or wastewater that
may contain coating-derived antimicrobial agents, and the
consequent potential for generation of antimicrobial
resistance.Generating the opinion
World Cafe´ fora were used to gather feedback to pre-
determined open questions. These fora, a form of group
consultation with larger numbers than usually involved in focus
groups, are designed to encourage discussion, whereby par-
ticipants share and contribute through a process of guided
facilitation [17,18]. AMiCI consortium members (N¼85) were
invited to participate having already registered to attend the
initial conference hosted by COST Action CA15114 AMiCI in
Heerlen, The Netherlands. In total, 75 participants from 24
European countries shared their opinions in the discussion fora.
Approximately 90% of the participants were from universities
or research institutes, while the remainder represented other
stakeholders such as hospital-based clinical microbiologists,
infection prevention and control nurses, hygiene product sup-
pliers, professional hygiene consultants and AMC producers.
Two weeks prior to the conference, participants were asked
to familiarize themselves with questions circulated to them via
e-mail. The discussions were preceded by a keynote lecture on
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Discussions were based on three primary questions, with sub-
questions, focusing specifically on new cleaning methods for
use in healthcare environments and their potential interactions
with AMCs when applied in those settings [14,15].
The questions were:
e What new (non-traditional) cleaning methods are being
introduced into healthcare settings?
e Is there belief or confidence in their effectiveness?
e When choosing cleaning methods, are cost in use, shelf-life
(or length of time they will be effective), special cleaning
or training, and other considerations including anti-
microbial resistance taken into consideration?
Findings
Question 1. What new (non-traditional) hygiene
methods are being introduced into healthcare
settings?
The 75 participants represented a pan-European perspec-
tive, with commonalities and differences in healthcare facility
cleaning practices. Few novel, non-detergent, non-disinfec-
tant hygiene practices were known to be in current use (see
below).
e H2O2. Used ubiquitously but not regularly, typically to
reduce the microbial burden of surfaces in a room following
an incidence of HCAI or discharge of a patient known to be
a carrier of a problematic multi-drug-resistant micro-
organism.
e Ultraviolet light. As above, but not allowed in the
Netherlands due to unacceptable efficacy compared with
chemical cleaning, in addition to concern regarding po-
tential damage to plastic surfaces.
e Ultrasonically-activated water. Not common. When used,
perceived as suitable for use on all surfaces due to absence
of resulting chemical residue and gentle action. The effect
is physical removal but not killing of microbes.
e Microfibre materials. Used ubiquitously. Effective for
removal of micro-organisms and physical dirt. Used with
water alone in the Netherlands and Germany, while used
with detergents/disinfectants elsewhere. Also used with
detergents and/or disinfectants in Germany and
Switzerland.
e Plant oils and acids. Not common (e.g. lauric acid and
peracetic acid are used for disinfection of instruments or
equipment if automatic processing cannot be performed).
e Formic acid in water. Not common
e Bacteriophage (‘phage’). Not common.Question 2: Is there belief or confidence in their
effectiveness?
The dominant view expressed was one of caution. The
reputational damage to a healthcare facility, in addition to the
actual effects on patient and staff health, due to outbreak of
an HCAI can be significant. Consequently, there is reticence to
adopt new approaches in place of existing, recognized cleaningprocedures. Where new cleaning processes are adopted, they
seem to be introduced into practice in parallel with, and even
complementary to, traditional detergent- or disinfectant-
based systems.
Surprisingly, in an era when confidence in a process or
product should, ideally, be based on evidence and scientific
data, most participants stated that decision-making stake-
holders placed considerable credence on products that had a
‘clean smell’. In other words, there appears to be a psycho-
logical association between the smell of alcohol, disinfectant
and detergent and their perceived effectiveness. For that
reason, perhaps, there was a unanimous lack of confidence
regarding steam cleaning, while strong odours (e.g. formic acid
acetic acid/chlorine) would perhaps be more widely accepted.
Worryingly, there was also a general lack of confidence in the
adequacy of training provided to cleaning staff, and a lack of
awareness of accreditation such as, for example, that provided
by the British Institute of Cleaning Science (https://www.bics.
org.uk). More specifically, there was consensus regarding the
poor quality of training provided to hospital cleaning staff who,
irrespective of country, appear to be relatively poorly educated
and of lower socio-economic status. Typically, these workers
are employed on temporary contracts and are not, usually, in-
tegrated fully into medical teams, and instead represent
‘invisible’ support staff. As such, views were expressed that
these support staffmay not be considered capable (by clinicians
or hospital management) of implementing innovative or
technologically-advanced cleaning processes beyond the ‘mop
and bucket’ approaches used traditionally. Consequently, the
perceived risk of potential failuremay dissuade decisionmakers
from adopting new cleaning methods.Question 3. When choosing cleaning methods, are cost
in use, shelf-life (or length of time they will be
effective), special cleaning or training, and other
considerations including antimicrobial resistance
taken into consideration?
Proof of efficacy was a consistent need for all participants,
as was regulatory approval or licence for use in their country.
Similarly, there was consensus that new cleaning approaches
would not be implemented, or even trialled, at their respective
facilities unless:
e promoted by credible, well-established supply companies
with good reputations;
e evidence demonstrated that their use did not damage
existing surfaces;
e there would not be significant training requirements for
clinical and facility management staff and, especially,
cleaning staff;
e new cleaning products were compatible with existing
cleaning processes and chemicals;
e excessive or expensive additional or specialist equipment
was not needed, especially personal protective equipment;
and
e crucially, that cost-effectiveness had been documented.
Another, but not consistently expressed, perspective was
the fact that while cost in use was an important consideration,
there should also be some estimation made regarding cost
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enhanced effectiveness of cleaning and subsequent decreased
clinical care expenditure. However, there was general agree-
ment that this calculation may not be persuasive when facility
managers are looking at short-term annualized budgeting.
An interesting problem was also identified with respect to
Proof of efficacy. Most participants stated that new cleaning
approaches would not be introduced in their hospital unless
proven to work elsewhere. This represents a ‘catch 22’ situa-
tion with clear challenges regarding potential sites at which to
assess innovations.
Generation of antimicrobial resistance was discussed at
length, and acknowledged as a major challenge for use of AMCs
in general, and cleaning processes in particular. More specif-
ically, all participants were aware that cleaning processes
would be likely to remove small amounts of biocides from AMCs
when applied to hospital surfaces [15e19]. Such chemicals are
inherently toxic and may be harmful to humans and animals
[16]. Indeed, compounds containing silver, copper and zinc
(described previously in this article) are covered within the
European Union by the Biocidal Product Regulation [Regulation
(EU) 528/2012] and Regulation (EC) No 1907/2006 of the Eu-
ropean Parliament and of the Council on the Registration,
Evaluation, Authorization and Restriction of Chemicals.
Therefore, appropriate treatment of hospital wastewater and
cleaning effluent, potentially containing either biocides or
multi-drug-resistant bacteria, requires clarification. Effluent-
free cleaning would present significant benefits for risk
reduction.
There was unanimous agreement that the generation of
scientific guidelines for cleaning of AMCs, using traditional or
new processes, is needed. There should be particular emphasis
on:
e understanding the mechanisms of action of cleaning ma-
terials (chemicals and textiles) and their physical in-
teractions with conventional coatings and AMCs;
e evaluation of these cleaning processes on newly applied
coatings, and that assessments further mimic the life cycle
of coatings to determine the impact of repetitive cleaning
and other aspects of ageing (e.g. exposure of surfaces to
sunlight, etc.). This was a key point that was expanded to
discuss the distinctions between antimicrobial paints that
could, if needed, be readily re-applied compared with
products manufactured with antimicrobial surface prop-
erties that, if worn over time, may not be re-applied easily
and must instead be replaced entirely, possibly with asso-
ciated disruption and costs;
e determining the concentrations of biocides in effluents,
based on interactions with cleaning chemicals and mate-
rials, and their residual antimicrobial activity;
e development of effective de-activation and sterilization
treatments for cleaning effluents. These may also involve
removal of biocides and/or multi-drug-resistant micro-or-
ganisms; and
e all of the above apply equally to cleaning materials such as
textiles and other physical cleaning equipment.
Discussion
Participants of this study spanned clinical practice, aca-
demic research, industry and regulatory agencies. However,there was general consensus and acknowledgement of analo-
gous experiences regarding hospital cleaning practices across
more than 20 countries. Agreeing with the perspectives on
hospital cleaning ‘dos and don’ts’ described by Dancer [20],
each of the participants detailed resource-constraint-driven
changes to hospital hygiene practices. These included
outsourcing of cleaning services to commercial providers, and
subsequent infection prevention and control failures or
perceived detrimental effects on effectiveness, knowledge,
attitudes and practices of relatively low paid and typically
poorly educated workers [21e24]. The participants believed
these factors to be important determinants of potential suc-
cess or failure for AMCs. Specifically, irrespective of their
antimicrobial properties, coatings are unlikely to impact the
incidence of HCAIs if they are not cleaned thoroughly and
bioburden, molecular or cultivable material is not removed
effectively. This has been discussed previously, with credible
arguments given regarding poor training and motivation of
cleaning staff [22,25e27].
It was especially notable that during discussion of Question
1, none of the participants referred to practical experience of
AMC use at clinical facilities, other than in experimental set-
tings. Indeed, there was consensus regarding a need for clarity
regarding the potential efficacy claims for AMCs or ‘expecta-
tion management’. Put more simply, if those who have re-
sponsibility for clinical facility management are to adopt their
use and be convinced of their benefit, AMC products need to
have credible, unambiguous trial data relevant to the intended
environment in which they are to be used and the microbes
targeted (e.g. vegetative cells or spores). However, in the
context of associated specialized AMC-related cleaning prac-
tices, the participants recognized that with notable exceptions
[28], there was a paucity of prospective, appropriately
controlled, crossover trials of hygiene products or practices,
irrespective of whether used on standard or enhanced
surfaces.
Participants reiterated concerns regarding the potential of
AMCs to promote development of antimicrobial resistance
mechanisms, as described elsewhere [16]. Multi-drug-resistant
bacteria have been identified in waterways contaminated by
effluent of ineffective hospital wastewater treatment [29].
While these reports relate to antibiotic resistance, there is
potential for non-antibiotic leachates from AMCs borne in
cleaning equipment (e.g. mops and buckets) to introduce non-
inhibitory levels of antimicrobial agents into sewage and
ground water. For that reason, AMC cleaning procedures should
stipulate suitable, and possibly dedicated, disposal processes
to reduce or negate the risk of such environmental
contamination.
Therefore, the recommendations of this group, derived
from disparate but complementary expertise, acknowledge the
potential benefit of AMCs and the strong likelihood that such
products will enter use. This is almost an inevitability due to
pressures on the healthcare industry to adopt attractive
propositions claiming reduction of infection risk in their facil-
ities, and the increasing marketing pressure from manufac-
turers and distributors. However, this group recommends the
use of AMCs as part of suites of practices that include avail-
ability of well-characterized cleaning materials and processes,
training (and accreditation) of cleaning staff, and environ-
mental monitoring. In particular, the latter should consider the
potential impact on organisms living in water and soil
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antimicrobial agents that may induce resistance that differs
from antibiotic-driven mechanisms. Furthermore, the
consensus view is that, prior to widespread implementation of
AMCs, the varying responsibilities of the involved stakeholders
should be clarified. Specifically:
e analogous to European directives stipulating the level of
scientific evidence required for food supplement claims or
drug efficacy, there should be minimal data requirements
regarding safety (e.g. contact sensitivity, conduction of
electricity or other workplace safety concerns) and Proof
of efficacy for specific AMC formulations that have been
assessed in suitable environments. This may require
appropriately powered, blinded, controlled trials;
e instructions for care of AMCs following deployment for use
should include evidence-based directions regarding their
cleaning with specified cleaning material types (chemical,
textiles materials, etc);
e appropriate and understandable information should be
provided to allow effective training of clinical, manage-
ment and cleaning staff prior to use of AMCs. Such training
must also include understanding of potential contact
sensitivity risks and use of suitable personal protection
equipment when appropriate; and
e environmental monitoring protocols should be adopted to
allow efficient and effective detection and measurement
of potential presence or effects of AMC-derived active
agents. Actions for remediation and those responsible for
their implementation should be explicit.Conflict of interest statement
None declared.
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